These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27925332)

  • 1. Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome.
    Bellmann B; Schnupp S; Kühnlein P; Javernik C; Kleinecke C; Rillig A; Landmesser U; Brachmann J; Park JW
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):315-320. PubMed ID: 27925332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
    Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to treat residual peridevice leakage after left-atrial appendage closure.
    Wunderlich N; Wilson N; Sievert H
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):313-9. PubMed ID: 23629764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.
    Jaguszewski M; Manes C; Puippe G; Salzberg S; Müller M; Falk V; Lüscher T; Luft A; Alkadhi H; Landmesser U
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):306-12. PubMed ID: 25205611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
    Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study.
    Huang H; Liu Y; Xu Y; Wang Z; Li Y; Cao K; Zhang S; Yang Y; Yang X; Huang D; Yu B; Su X; Wu L; Huang C
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2188-2194. PubMed ID: 29122133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure.
    Della Rocca DG; Horton RP; Di Biase L; Bassiouny M; Al-Ahmad A; Mohanty S; Gasperetti A; Natale VN; Trivedi C; Gianni C; Burkhardt JD; Gallinghouse GJ; Hranitzky P; Sanchez JE; Natale A
    JACC Cardiovasc Interv; 2020 Feb; 13(3):306-319. PubMed ID: 31954677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-based closure of residual leaks after percutaneous occlusion of the left atrial appendage.
    Hornung M; Gafoor S; Id D; Vaskelyte L; Hofmann I; Franke J; Sievert H; Bertog SC
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1324-30. PubMed ID: 26698175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome.
    Wolfrum M; Attinger-Toller A; Shakir S; Gloekler S; Seifert B; Moschovitis A; Khattab A; Maisano F; Meier B; Nietlispach F
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):656-664. PubMed ID: 27465268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
    Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
    Asmarats L; Masson JB; Pagnotta PA; Cook S; Foresti M; Ibrahim R; Sukiennik A; Sabiniewicz R; Maffeo D; Carballo J; Cruz-González I; Grasso C; Pisano F; Senatore G; Tarantini G; Kasongo A; Chiarito M; Puricel S; Messas N; Moreno-Samos JC; O'Hara G; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Oct; 11(19):1932-1941. PubMed ID: 30249439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Berti S; Pastormerlo LE; Rezzaghi M; Trianni G; Paradossi U; Cerone E; Ravani M; De Caterina AR; Rizza A; Palmieri C
    Heart; 2016 Dec; 102(24):1969-1973. PubMed ID: 27492943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.